Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Annurca apple extract may help with hair growth and prevent hair loss.

Engineered exosomes with EGF and FGF improve hair growth in mice with hair loss.

Targeting the narrowest part of the anterior chamber angle may help prevent pupil block in glaucoma.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Combining growth factors with minoxidil improves hair growth more than minoxidil alone.

Engineered exosomes with EGF and FGF improved hair growth in mice with hair loss.

Blocking α1-integrin makes adult fibroblasts more like foetal ones, improving their movement and aiding wound healing.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

Titanium nanoparticles may trigger frontal fibrosing alopecia, so avoid products with them.

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.